See Why Leading Radiologists Are Upgrading to cvi42 This November - Visit Circle at RSNA Booth #7961
Highlights
- The latest release of cvi42 v6.4 focuses on workflow efficiency and leveraging artificial intelligence
- In-house post-processing speeds reporting time and captures more reimbursement
- Circle’s vascular capabilities expand with the addition of cvi42 | Vascular CT
- New business models increase the flexibility and accessibility for reporting physicians
CALGARY, Alberta, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Circle Cardiovascular Imaging (Circle CVI), the market leader in cardiovascular imaging post-processing will unveil its latest release at the Radiological Society of North America (RSNA) Annual General Meeting being held November 30 – December 4 in Chicago, IL. Circle CVI will demonstrate its newest release, cvi42 v6.4.
Radiology leaders know that efficiency, accuracy, and practice growth are non-negotiable. At RSNA 2025, Circle Cardiovascular Imaging invites you to experience the new cvi42 release - a solution engineered to grow your CCT and CMR business.
What cvi42 can do for your practice:
- Reduce Reporting Times:
Native integration with PowerScribe automates transcription, minimizing error risk and freeing clinical teams to focus on interpretation rather than manual data entry. - Accelerate Patient Care:
In-house plaque analysis with cvi42 enables faster turnaround times, supporting timely diagnosis and allowing you to deliver a higher standard of care. - Drive Confidence and Adoption:
cvi42 | Vascular CT follows best practices with automated contouring, lowering barriers to using advanced CT vascular analysis - so teams adopt new capabilities faster. - Increase Revenue Capture:
With cvi42 | Plaque you pay for what you process at a fraction of the price of outsourcing and increase your throughput with a streamlined workflow. - Elevate Value and Flexibility:
Our new subscription model provides scalable access to CMR and CCT functionalities ensuring your team has unlimited access to work from anywhere.
“With our latest cvi42 release, we’re helping practices unlock greater efficiency, deliver faster patient care, and build a scalable foundation for the future of cardiovascular imaging while supporting business growth” said Chris Bazinet, Chief Revenue Officer of Circle CVI. “We are excited to see how our customers respond to the latest innovations and hear from them how we are solving their challenges”
Benefits for Radiology Leaders and Decision Makers:
- Minimized risk of error in reporting
- Improved workflow efficiency, leading to reduced burnout
- Faster reporting speeds, translating to greater practice performance
- Flexibility to scale and capture new revenue streams
- Technology that aligns with evolving best practices and reimbursement guidelines
Join Us at RSNA 2025 - Shape the Future of Cardiovascular Imaging
Nov. 30 – Dec. 3 | Booth #7961, North Hall
Secure your demo now - see how cvi42 can help you lead with confidence and results.
Enquiries
Circle Marketing
marketing@circlecvi.com
ABOUT CIRCLE CARDIOVASCULAR IMAGING
Circle Cardiovascular Imaging Inc. (Circle CVI) is a Canadian-based company founded in 2007 with a mission to develop innovative software solutions that enhance cardiovascular and cerebrovascular imaging analysis and ultimately improve patient care. Circle’s flagship platform, cvi42, delivers best-in-class image reading and reporting tools for quantitative and qualitative assessment of cardiac MR, cardiac CT, vascular CT, and neuro CT.
At the core of Circle’s work is a relentless commitment to empowering healthcare providers with advanced, intuitive tools that lead to better healthcare outcomes. This passion for innovation, rooted in both medicine and technology, drives Circle’s global impact and fuels a culture of excellence.
Today, millions of medical imaging exams each year—across 1,700+ hospitals in over 90 countries—are interpreted using Circle’s cvi42 platform.
For more information, please visit www.circlecvi.com or contact: marketing@circlecvi.com

Source(s) : Circle Cardiovascular Imaging Inc.